FDA Daily
The FDA briefing, now part of ScholarDaily.
FDA Daily is now part of ScholarDaily. Its briefing continues inside ScholarDaily, where one subscription unlocks every briefing. This page, its privacy policy, and its terms stay online for reference.





FDA Daily is now part of ScholarDaily. Its weekday briefing, which turns the U.S. FDA's public record (drug approvals, device clearances and approvals, recalls, and drug shortages) into plain-language briefs with a link back to each FDA record, ships as one of seven official-source briefings in ScholarDaily, where one subscription unlocks them all. FDA Daily is not offered as a separate app.
Features
A weekday briefing of the FDA actions that matter, across drug approvals, device clearances, device approvals, recalls, and drug shortages.
Plain-language what happened, key details, and what it means — with the FDA record behind every brief.
Read inside ScholarDaily, with its archive and search, alongside six other official-source briefings under one subscription.
Key questions
What is FDA Daily?
FDA Daily is now part of ScholarDaily. Its weekday briefing, which turns the U.S. FDA's public record (drug approvals, device clearances and approvals, recalls, and drug shortages) into plain-language briefs with a link back to each FDA record, ships as one of seven official-source briefings in ScholarDaily, where one subscription unlocks them all. FDA Daily is not offered as a separate app. Core workflow: A weekday briefing of the FDA actions that matter, across drug approvals, device clearances, device approvals, recalls, and drug shortages.
Which platforms does FDA Daily support?
FDA Daily supports iOS.
How does FDA Daily handle data?
FDA Daily stores your watchlist choices, reading feedback, and reminder settings on your device only. They are never sent to its server. The backend keeps no account, no profile, and no per-reader activity — it serves the same daily briefing to everyone. Reader data is not sold and not shared. There is no analytics SDK and no advertising identifier. Payment processing and subscription status are handled by Apple. Source material remains public U.S. FDA record.